logo

EW

Edwards Lifesciences·NYSE
--
--(--)
--
--(--)

EW fundamentals

Edwards Lifesciences (EW) released its earnings on Feb 10, 2026: revenue was 1.57B (YoY +13.26%), beat estimates; EPS was 0.58 (YoY -1.69%), missed estimates.
Revenue / YoY
1.57B
+13.26%
EPS / YoY
0.58
-1.69%
Report date
Feb 10, 2026
Earnings Call
5:00 PM on Feb 10, 2026
Meeting link.
EPS
Revenue

Revenue & Expenses

EW has released its 2025 Q4 earnings report, with revenue of 1.57B, reflecting a YoY change of 13.26%, and net profit of 91.20M, showing a YoY change of -76.27%. The Sankey diagram below clearly presents EW's revenue sources and cost distribution.

Key Indicators

Edwards Lifesciences (EW) key financial stats and ratios, covering profitability, financial health, and leverage.
Edwards Lifesciences (EW)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Edwards Lifesciences (EW)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Edwards Lifesciences (EW)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Edwards Lifesciences (EW) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Edwards Lifesciences (EW) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield